We report a case of scoliosis, fracture of the neck of the femur and ochronosis occurring together in a patient.

Purpose: To test the significance of calcar referenced tip-apex distance (CalTAD) and the length of anti-rotation screw (AR screw) as predictors for failure after biaxial cephalomedullary (CM) nailing of intertrochanteric fractures. Methods: We retrospectively reviewed 190 consecutive fractures that had undergone biaxial CM nailing. Of these, 67 met the inclusion criteria of a non-pathological fracture with a minimum of 90 days radiological follow-up (mean 458 days; 91 days to 4.9 years). Results: The overall failure rate was 15% (10 of 67). Failure was associated with a higher CalTAD in most of the patients (13%, p < 0.001). A higher tip-apex distance (TAD) was not significantly associated with failure (p ¼ 0.132), when the CalTAD was less than 25 mm. When the AR screw length exceeded a line connecting the tip of the nail and the lag screw, screw cutout occurred only in one patient (p ¼ 0.095). Conclusion: Our data provide the first reported clinical evidence that the CalTAD is a better predictor of cutout in biaxial CM nailing than TAD measurement. However, the length of anti-rotational element does not seem to be an independent predictor of CM nailing failure.

No abstract

BACKGROUND An intertrochanteric fracture occurs between the greater trochanter and the lesser trochanter, which is common in old age. If treated non-operatively, malunion with coxa vara deformity resulting in shortening of limb are commonly seen. Intertrochanteric femur fractures may be fixed with either a sliding hip screw or an intramedullary nail. Problem with sliding hip screw is collapse of the femoral neck, leading to loss of hip offset and shortening of the leg. Therefore, a new intramedullary device-proximal femoral nail (PFN) was designed which gave an advantage of minimally invasive surgery. Objectives-To determine the functional outcome of intertrochanteric fracture treated with proximal femoral nail (PFN) by using Harris Hip Score (HHS).

<p><strong>Background:</strong> The prevalence of knee osteoarthritis (OA) is estimated to be 14%<strong> </strong>and 6% in rural and<strong> </strong>urban areas of India, respectively. In severe cases, the American Academy of Orthopedics Surgeons recommends non-steroidal anti-inflammatory drugs (NSAIDs). A prospective interventional study was conducted to evaluate the effectiveness of intra-articlular hyaluronic acid injection (IAHA) in knee OA patients.</p><p><strong>Methods:</strong> Medical records of 29 patients with knee OA, who were treated with IAHA injection, were analyzed using a 24 item WOMAC scale for the pain, stiffness, and physical function scores. Furthermore, the patients’ quality of life was evaluated based on the SF-12 scale and a global status assessment of knee OA was performed using the Likert scale and visual analogue scale (VAS). The data were analysed statistically.</p><p><strong>Results:</strong> The overall WOMAC pain, stiffness, and physical function scores decreased following the IAHA administration in patients with knee OA. The mean pain scores decreased from 10.82 to 3.62 and stiffness scores dropped from 4.34 to 2.03. The mean physical function scores decreased from 36.75 to 17.1 (p&lt;0.0001). The Likert scale and VAS demonstrated statistically significant (P &lt; 0.0001) improvement in the patient’s health status. Overall, nearly 80% of the patients expressed little-to-none physical or emotional problems four weeks after IAHA treatment.</p><p><strong>Conclusions: </strong>A single IAHA injection provided statistically significant improvement in pain, disability, and quality of life in knee OA patients. </p>